Aptose Biosciences Inc.
APTO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$25,430 | -$51,207 | -$41,823 | -$65,354 |
| Dep. & Amort. | $404 | $466 | $528 | $622 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,060 | $3,653 | $5,207 | $12,949 |
| Change in WC | -$11,025 | $2,449 | $4,317 | $1,516 |
| Other Non-Cash | -$986 | $49 | -$551 | $6,963 |
| Operating Cash Flow | -$35,977 | -$44,590 | -$32,322 | -$43,304 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5 | -$29 | -$24 | -$212 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$34,996 |
| Inv. Sales/Matur. | $0 | $9,989 | $28,898 | $0 |
| Other Inv. Act. | $23 | $0 | $1,192 | $0 |
| Investing Cash Flow | $18 | $9,960 | $30,066 | -$35,208 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $10,000 | $0 | $0 | $0 |
| Stock Issued | $23,407 | $6,881 | $101 | $36 |
| Stock Repurch. | $26 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $28 | $29 | $15 | $190 |
| Financing Cash Flow | $33,414 | $6,910 | $116 | $226 |
| Forex Effect | $0 | $2 | -$4 | $7 |
| Net Chg. in Cash | -$2,545 | -$27,718 | -$2,144 | -$78,279 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9,252 | $36,970 | $39,114 | $117,393 |
| End Cash | $6,707 | $9,252 | $36,970 | $39,114 |
| Free Cash Flow | -$35,982 | -$44,619 | -$32,346 | -$43,516 |